NakamotoH.Encapsulating peritoneal sclerosis—a clinician's approach to diagnosis and medical treatment.Perit Dial Int2005; 25(Suppl 4): S30–8.
6.
LambieM., BraunN., DaviesS.J.Towards standardized reporting in studies of encapsulating peritoneal sclerosis.Perit Dial Int2013; 33: 482–6.
7.
CampiseM.Neurological complication during imipenem/cilastatin therapy in uraemic patients.Nephrol Dial Transplant1998; 13: 1895–6.
8.
YangS.C., HsuehP.R., LaiH.C., TengL.J., HuangL.M., ChenJ.M.High prevalence of antimicrobial resistance in rapidly growing mycobacteria in taiwan.Antimicrob Agents Chemother2003; 47: 1958–62.
9.
LoM.W., MakS.K., WongY.Y., LoK.C., ChanS.F., TongG.M.Atypical mycobacterial exit-site infection and peritonitis in peritoneal dialysis patients on prophylactic exit-site gentamicin cream.Perit Dial Int2013; 33: 267–72.
10.
SiddiqiN., SheikhI.Peritonitis caused by mycobacterium abscesses in patients on continuous ambulatory peritoneal dialysis.Saudi J Kidney Dis Transpl2012; 23: 321–4.
11.
RenaudC.J., SubramanianS., TambyahP.A., LeeE.J.The clinical course of rapidly growing nontuberculous mycobacterial peritoneal dialysis infections in asians: a case series and literature review.Nephrology (Carlton)2011; 16: 174–9.
12.
KameyamaH., MoriY., KimuraT., SugishitaC., AdachiT., SonomuraK.A case report of mycobacterium abscessus peritonitis in a peritoneal dialysis patient.Ther Apher Dial2007; 11: 449–51.
13.
DunmireR.B.3rd, BreyerJ.A.Nontuberculous mycobacterial peritonitis during continuous ambulatory peritoneal dialysis: Case report and review of diagnostic and therapeutic strategies.Am J Kidney Dis1991; 18: 126–30.
